| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Review |
| Article Title |
Nonalcoholic fatty liver disease and diabetes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maria Irene Bellini, Irene Urciuoli, Giovanni Del Gaudio, Giorgia Polti, Giovanni Iannetti, Elena Gangitano, Eleonora Lori, Carla Lubrano, Vito Cantisani, Salvatore Sorrenti and Vito D'Andrea |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Maria Irene Bellini, FEBS, MD, PhD, Assistant Professor, Surgeon, Department of Surgical Sciences, Sapienza University, Viale Regina Elena, Rome 00161, Italy. mariairene.bellini@nhs.net |
| Key Words |
Bariatric surgery; Diabetes; Hepatic steatosis; Liver fibrosis; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis |
| Core Tip |
Nonalcoholic fatty liver disease is the most common liver disease worldwide, characterized by fat accumulation in the hepatic parenchyma, with a range of different stages from mild inflammation to severe fibrosis. There is a biunivocal relationship with type 2 diabetes, with important consequences in terms of cardiovascular risk, which seems to also have occurred during the coronavirus disease 2019 pandemic. This review focuses on the pathogenesis, clinical aspects, and treatment, providing guidance for a non-invasive diagnosis and preferred therapy, medical and/or surgical. |
| Publish Date |
2022-09-09 15:45 |
| Citation |
Bellini MI, Urciuoli I, Del Gaudio G, Polti G, Iannetti G, Gangitano E, Lori E, Lubrano C, Cantisani V, Sorrenti S, D'Andrea V. Nonalcoholic fatty liver disease and diabetes. World J Diabetes 2022; 13(9): 668-682 |
| URL |
https://www.wjgnet.com/1948-9358/full/v13/i9/668.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v13.i9.668 |
